Drug Shortage Report for SANDOZ FESOTERODINE FUMARATE

Last updated on 2024-12-24 History
Report ID 237761
Drug Identification Number 02521776
Brand name SANDOZ FESOTERODINE FUMARATE
Common or Proper name FESOTERODINE FUMARATE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) FESOTERODINE FUMARATE
Strength(s) 8MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 100PRT
ATC code G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2024-09-16
Estimated end date Unknown
Actual end date 2024-12-23
Shortage status Resolved
Updated date 2024-12-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2024-12-24 English Compare
v8 2024-12-23 French Compare
v7 2024-12-23 English Compare
v6 2024-12-23 English Compare
v5 2024-12-10 French Compare
v4 2024-12-10 English Compare
v3 2024-09-17 English Compare
v2 2024-09-16 French Compare
v1 2024-09-16 English Compare

Showing 1 to 9 of 9